CDSCO extends deadline to submit details of 19 FDC drugs
New Delhi: Following several requests for an extension of the deadline for submitting information on the rationality, safety, and efficacy of pre-1988 permitted Fixed Dose Combinations (FDCs), the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), has extended the deadline to October 25th, 2021 at 5:00 PM, from August 25th, 2021 at 5:00 PM.
Earlier, the Medical Dialogue Team had reported that in order to assess the status of fixed dose combination drugs licensed prior to 1988, the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO) expert committee had invited concerned stakeholders to submit information on the rationality, safety, and efficacy of such fixed dose combinations (FDCs) in the specified format.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.